Imagine that one day, you wake without any memory of your friends and family. The people you've come to know and love all your life are gone, with strangers now standing in their place. Little by little, you begin to lose more and more of your memories and, ultimately, yourself until there is nothing left but a hollow shell.
So yeah, Alzheimer's disease isn't too fun (Webster's dictionary actually accepts it as a synonym for the phrase "not fun". True fact.). Researchers have devoted a lot of time and money towards fighting the ailment, but they haven't had all that much to show for it.
Well, until now, that is.
Of course there is still a lot of work that has to be done until we're anywhere near finding a way to eradicate the disease. It's an important breakthrough nonetheless, and could eventually lead to an effective treatment. Plus, it looks like enhanced Apes won't have to be involved. That's a plus for us!
There may come a time when people will no longer remember the pain and heartbreak of Alzheimer's disease; you could say it will be getting a taste of its own medicine.
So yeah, Alzheimer's disease isn't too fun (Webster's dictionary actually accepts it as a synonym for the phrase "not fun". True fact.). Researchers have devoted a lot of time and money towards fighting the ailment, but they haven't had all that much to show for it.
Well, until now, that is.
Karolinksa Institutet[NEWS 6 June] A study led by Karolinska Institutet reports for the first time the positive effects of an active vaccine against Alzheimer's disease. The new vaccine, CAD106, can prove a breakthrough in the search for a cure for this seriously debilitating dementia disease. The study is published in the distinguished scientific journal Lancet Neurology.
Alzheimer's disease is a complex neurological dementia disease that is the cause of much human suffering and a great cost to society. According to the World Health Organisation, dementia is the fastest growing global health epidemic of our age. The prevailing hypothesis about its cause involves APP (amyloid precursor protein), a protein that resides in the outer membrane of nerve cells and that, instead of being broken down, form a harmful substance called beta-amyloid, which accumulates as plaques and kills brain cells.
...The new treatment, which is presented in Lancet Neurology, involves active immunisation, using a type of vaccine designed to trigger the body's immune defence against beta-amyloid. In this second clinical trial on humans, the vaccine was modified to affect only the harmful beta-amyloid. The researchers found that 80 per cent of the patients involved in the trials developed their own protective antibodies against beta-amyloid without suffering any side-effects over the three years of the study. The researchers believe that this suggests that the CAD106 vaccine is a tolerable treatment for patients with mild to moderate Alzheimer's. Larger trials must now be conducted to confirm the CAD106 vaccine's efficacy.
Of course there is still a lot of work that has to be done until we're anywhere near finding a way to eradicate the disease. It's an important breakthrough nonetheless, and could eventually lead to an effective treatment. Plus, it looks like enhanced Apes won't have to be involved. That's a plus for us!
There may come a time when people will no longer remember the pain and heartbreak of Alzheimer's disease; you could say it will be getting a taste of its own medicine.